BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MDS Diagnostic Services (MDZ) Announces Sale Of Laboratory Operations In New York And Georgia To Laboratory Corporation of America® Holdings (LH)


10/19/2005 5:10:27 PM

TORONTO, March 16 /PRNewswire-FirstCall/ -- MDS Diagnostic Services has sold its laboratory operations in Poughkeepsie, NY and Atlanta, GA, to Laboratory Corporation of America(R) Holdings (LabCorp(R)) in an asset purchase transaction, effective March 15, 2004. Financial terms of the transaction have not been disclosed.

LabCorp immediately assumes responsibility for these operations, including employees and facilities in both locations, and will work with MDS to ensure a smooth transition for customers and employees.

"Late in 2003, we indicated that the US laboratory business had not been meeting our performance expectations. This sale is a necessary step in repositioning the US laboratory business at MDS and will have a positive impact on our operations going forward," said Cam Crawford, President, MDS Diagnostic Services.

The sale is a result of a comprehensive review of MDS US laboratory operations and a resulting change in the US laboratory strategy. This transaction does not affect its joint-venture operations at the Memphis Pathology Laboratory (MPL) and at Integrated Regional Laboratories (IRL) in Florida and its relationship with the Duke University Health System Clinical Laboratories.

MDS Diagnostic Services is part of MDS Inc., an international health and life sciences company (NYSE: MDZ; TSX: MDS). At MDS Inc., more than 10,000 highly skilled people provide enabling products and services for the development of drugs and the diagnosis and management of disease. MDS focuses on helping discover and test new drugs, assisting doctors to diagnose and treat patients and preventing the spread of disease. Find out more about MDS Inc. (TSX: MDS; NYSE: MDZ), at http://www.mdsintl.com/ or by calling 1-888-MDS-7222, 24 hours a day.

MDS Diagnostic Services

CONTACT: Sharon Mathers, Vice President, Investor Relations, MDS Inc.,(416) 675-6777 x 2695


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->